
Protocol Magnesium Citrate 400 mg 100 Tablets
100 tablets
Key benefits
- Provides 400 mg of magnesium per serving
- Supports cardiovascular system health
- Helps support strong and healthy bones
- Helps prevent magnesium deficiency, muscle cramps, and fatigue
- Vegetarian and vegan formulation manufactured in a GMP facility
About this product
A dietary supplement providing 400 mg of highly absorbable magnesium citrate per serving. It supports cardiovascular and bone health while helping to prevent magnesium deficiency. Individuals seeking to support heart and bone health or prevent magnesium deficiency, fatigue, and muscle cramps Tablets
Key ingredients
- Magnesium (as Magnesium Citrate) — Essential mineral that supports heart and bone health and helps prevent magnesium deficiency
How to use
- 1
Take two tablets daily as a dietary supplement
- 2
Preferably take with meals, or as directed by your healthcare practitioner
Product details
- Warnings
- Consult your healthcare practitioner before use if you are pregnant or nursing. Discontinue use and consult a doctor if any adverse reactions occur. Keep out of reach of children.
- Storage
- Store in a cool, dry place after opening.
- Country of origin
- USA
- Pack size
- 100 tablets
- Certifications
- gmp
Pairs well with

Protocol DHA-1000 Fish Oil for Cardiovascular and Brain Health Support, 90 Softgels
Frequently asked questions
What is Protocol Magnesium Citrate 400mg?
It is a dietary supplement containing Magnesium Citrate, a highly bioavailable form of magnesium to support muscle and nerve function and bone health.
What are the benefits of Magnesium Citrate?
Magnesium contributes to normal muscle and nerve functions, supports bone and teeth health, and aids in reducing fatigue and tiredness.
How do I use Magnesium Citrate 400mg?
Take one tablet daily with water, preferably with a meal, or as directed by your healthcare provider.
Is this product suitable for vegetarians?
Yes, this product is suitable for vegetarians.
Related products
Customer reviews
Reviews
No reviews yet




